Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug

Cisplatin and other DNA-damaging chemotherapeutics are widely used to treat a broad spectrum of malignancies. However, their application is limited by both intrinsic and acquired chemoresistance. Most mutations that result from DNA damage are the consequence of error-prone translesion DNA synthesis,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Xu, Xiaoyang, Xie, Kun, Zhang, Xue-Qing, Pridgen, Eric M., Park, Ga Young, Cui, Danica S., Shi, Jinjun, Wu, Jun, Kantoff, Philip W., Lippard, Stephen J., Langer, Robert, Walker, Graham C., Farokhzad, Omid C.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2013
Teme:
Biological Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832000/
https://ncbi.nlm.nih.gov/pubmed/24167294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1303958110
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki